Applied DNA Sciences, Inc. (BNBX) financials · $3.3M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Applied DNA Sciences, Inc. (BNBX) $3.3M cap.
| Line | Q3 2026 | Q2 2026 |
|---|---|---|
| Revenue | $605.3K | $1.02M |
| Cost of Revenue | $158.2K | $197.3K |
| Gross Profit | $447.1K | $826.8K |
| Operating Income | -$3.24M | -$6.75M |
| Net Income | -$4.69M | -$6.67M |
| EPS (Diluted) | -$0.57 | -$0.68 |
| Line | Q3 2026 | Q2 2026 |
|---|---|---|
| Total Assets | $15.0M | $13.6M |
| Current Assets | $5.45M | $2.68M |
| Cash & Equivalents | $3.76M | $949.1K |
| Inventory | $27.0K | $115.4K |
| PP&E | $144.2K | $173.7K |
| Total Liabilities | $2.03M | $1.50M |
| Current Liabilities | $942.6K | $1.47M |
| Shareholders' Equity | $9.46M | $12.5M |
| Retained Earnings | -$409.2M | -$404.5M |
| Line | FY2024 | FY2023 |
|---|---|---|
| Operating Cash Flow | -$13.7M | -$6.22M |
| CapEx | $407.9K | $78.4K |
| Investing Cash Flow | -$407.9K | -$1.10M |
| Financing Cash Flow | $13.4M | N/A |
| Net Change in Cash | -$720.7K | -$7.31M |
| Free Cash Flow | -$14.1M | -$6.30M |
FAQ
What is BNBX P/E and revenue?
Applied DNA Sciences, Inc. (BNBX) $3.3M cap.
What is BNBX revenue?
Applied DNA Sciences, Inc. last cached revenue is $605.3K (Q3 2026).
Is BNBX profitable?
Applied DNA Sciences, Inc. last cached net income is -$4.69M (Q3 2026).
What are BNBX total assets?
Applied DNA Sciences, Inc. last cached total assets are $15.0M (Q3 2026).
What is BNBX free cash flow?
Applied DNA Sciences, Inc. last cached free cash flow is -$14.1M (FY2024).
Not investment advice. Cached statements, not a live tape.